• Ruthenium Red in Calcium Signaling Research

  2026-08-18

  Ruthenium Red is a water-soluble Ca2+ transport inhibitor for dissecting membrane calcium flux, mitochondrial calcium uptake, sarcoplasmic reticulum function, and mechanically induced signaling. This practical guide connects its use with cytoskeleton-dependent autophagy assays while emphasizing controls, solution handling, and interpretation limits.

• Sabutoclax for Apoptosis Response Assays

  2026-08-18

  Sabutoclax is a cell-permeable pan-Bcl-2 inhibitor for dissecting target engagement, growth suppression, and apoptosis in cancer models. This workflow pairs concentration-response profiling with time-resolved death measurements so researchers do not confuse metabolic arrest with genuine cell killing.

• SU5416: From VEGFR2 Blockade to PAH Models

  2026-08-17

  SU5416, also known as Semaxanib, is more than a cancer research angiogenesis inhibitor: it is a valuable tool for interpreting how VEGFR2 blockade reshapes vascular biology. This article connects its mechanism with proteomic biomarker research in pulmonary arterial hypertension while clarifying model-specific assay and dosing decisions.

• Mithramycin A: Mechanism and Research Workflow

  2026-08-17

  Mithramycin A is an anticancer antibiotic that binds G-C-rich DNA in the presence of divalent metal ions and can suppress transcriptional programs such as c-myc. This article defines its molecular rationale, evidence boundaries, and practical workflow for leukemia research and cancer biology research.

• Dacomitinib in Cancer Research: Workflow Guide

  2026-08-16

  Build a practical Dacomitinib workflow for linking irreversible ErbB signaling blockade with apoptosis, cell-cycle, and mitochondrial stress assays. The guide also shows how PF-00299804 can be used as a mechanistic perturbation in HER2-amplified breast cancer research, EGFR-driven lung models, and exploratory ferroptosis studies.

• E-4031 for 3D Cardiac Electrophysiology

  2026-08-15

  E-4031 provides a precise pharmacological challenge for hERG-dependent repolarization studies, including 3D organoid assays that go beyond conventional planar recordings. Paired with shell microelectrode arrays and calcium imaging, it helps connect QT interval prolongation-like electrical changes with spatial conduction and arrhythmogenic behavior.

• AO/PI Double Staining Kit for Cell Fate Profiling

  2026-08-14

  The AO/PI Double Staining Kit provides a rapid fluorescent readout that separates viable, apoptotic, and necrotic cells in one workflow. It is especially useful for drug-response screening, organoid studies, and post-isolation quality control where membrane integrity and cell-state differences must be assessed quickly.

• A-1210477: Mapping MCL-1 Dependency

  2026-08-14

  A-1210477 is a selective MCL-1 inhibitor for dissecting how cancer cells evade mitochondrial apoptosis. This guide develops a dependency-centered assay strategy that separates target-specific apoptotic rescue from nonspecific cytotoxicity and clarifies the compound’s in vitro research value.

• PAK1, mRNA Decay, and Oxaliplatin in Colorectal Cancer

  2026-08-13

  A recent Genes & Diseases study identifies PAK1 as a regulator of oncogenic mRNA stability in colorectal cancer, linking kinase activity to the persistence of several tumor-promoting factors. The work also reports strong synergy between the PAK1 inhibitor PF3758309 and Oxaliplatin, providing a mechanistic rationale for investigating PAK1-directed combination strategies in colorectal cancer models.

• Jasplakinolide: Designing Better Actin Assays

  2026-08-13

  Jasplakinolide is a membrane-permeable actin polymerization inducer that can reveal how filament stabilization reshapes cell behavior. This guide moves beyond product description to show how chemical-genetic logic, orthogonal readouts, and careful controls improve actin cytoskeleton research.

• DiscoveryProbe Library Plus: From Hits to Mechanism

  2026-08-12

  DiscoveryProbe Bioactive Compound Library Plus connects broad chemical perturbation with thermal-shift and orthogonal validation strategies. This article explains how to convert library hits into defensible pathway and target hypotheses across apoptosis, cancer research, and bacterial signaling.

• Amorolfine Hydrochloride in Yeast Integrity Assays

  2026-08-12

  Use Amorolfine Hydrochloride as a mechanistic probe for connecting fungal cell membrane disruption with ploidy-dependent stress. This workflow pairs growth, membrane, and transcriptional readouts so researchers can distinguish direct integrity defects from slower proliferation or high-ploidy baseline effects.

• HDAC Inhibitors and NUT Carcinoma: Study Insights

  2026-08-11

  Shiota et al. developed a dCAS9-based GFP reporter screen that identified structurally diverse HDAC inhibitors as repressors of NUT transcriptional activity. The study connects HDAC inhibition with BRD4-NUT megadomain disruption, tumor-cell differentiation, and improved xenograft responses when combined with bromodomain inhibition.

• MCL-1 Inhibition: From Mechanism to Translation

  2026-08-11

  MCL-1 inhibitor A-1210477 offers a precise way to interrogate mitochondrial apoptosis, MCL-1 dependence, and combination sensitivity in cancer models. This thought-leadership perspective connects its BIM-disrupting mechanism with breast cancer evidence, assay strategy, competitive positioning, translational interpretation, and practical limitations including unfavorable pharmacokinetics.

• ABT-263 (Navitoclax) in Reliable Assays

  2026-08-10

  Learn how ABT-263 (Navitoclax), SKU A3007, can improve experimental consistency in apoptosis, viability, and cancer biology workflows. This scenario-based guide covers mechanism, solvent compatibility, protocol handling, data interpretation, and practical supplier selection.

7916 records 2/528 page Previous Next 12345 下5页 Last page